Istituto Rudy Lanza - Alta formazione in Naturopatia

Istituto Rudy Lanza - Catalogo bibliografico delle tesi

Gli abstracts delle tesi in Naturopatia elaborate presso l'Istituto Rudy Lanza

Studio su alcuni rimedi vegetali e fitoterapici

Autore/autrice
Bevilacqua Luciana
Anno
2002
Numero
573

Abstract

Mossa da interesse e vera passione per il mondo del naturale, ho raccolto in questo lavoro informazioni e documentazioni su un certo numero di rimedi, sulle loro caratteristiche, attività principali e loro impiego terapeutico.

Certo la conoscenza e l’uso delle erbe medicinali si perde nella notte dei tempi, quando l’uomo e la donna si affidavano totalmente alla natura e avevano imparato a distinguere le erbe benefiche da quelle malefiche. Scelta spontanea degli animali, i quali sanno d’istinto quali sono le erbe loro utili.

Purtroppo però, con l’avanzare della medicina scientifica e dell’estendersi dell’urbanizzazione delle città, molte conoscenze si vanno perdendo insieme alla possibilità di reperire materialmente le erbe più rare o più delicate. È nelle campagne, infatti, che ritroviamo ancora l’abitudine e la consuetudine all’uso di infusi di erbe e fiori. Si scopre così con stupore che sono innumerevoli le ricerche che continuamente si compiono su piante o rimedi che sono a conoscenza dell’uomo da migliaia di anni, e, con meraviglia, che pur essendo vegetali antichi, sono in grado di andare incontro e sostenere le necessità di salute dell’uomo di oggi. Io, personalmente, mi sono avvicinata a questi studi nel periodo della mia gravidanza proprio per prepararmi a crescere ed allevare, e nella necessità curare il più possibile, con la medicina naturale mia figlia.

Le specialità di seguito elencate in questo studio sono riferibili a svariate patologie con differenti modalità di approccio terapeutico.

La prima parte è dedicata a quei rimedi che fanno da barriera ai processi ossidativi, quella lenta e terribile asfissia che toglie gravemente vitalità al nostro organismo. Leggiamo che un terzo dei malesseri lamentati dall’uomo è per situazioni legate alle conseguenze dello stress.

Sappiamo che il nostro corpo possiede e usa processi e meccanismi delicati e potenti per reagire alle minacce esterne, ma che mantenersi in questo stato di allerta costa un gran quantità di energia. Se poi lo stimolo dello stress è prolungato nel tempo, o cronico, viene compromessa la possibilità da parte dell’organismo di mantenersi in omeostasi. Ecco che la fitoterapia con gli immunostimolanti ci suggerisce le soluzioni che forniscono al nostro organismo aiuti per fare fronte alle necessità quotidiane.

Ho trovato poi due piante che lavorano come ipoglicemizzanti -da sole o in sinergia- e mi hanno incuriosito. Certo perchè il diabete è una patologia in forte aumento anche in età giovanile, ma nel caso del diabete insulino-indipendente, ho notato (per esperienza famigliare) che è molto difficile imporre a un soggetto una cura partendo solo da una dieta rigida; è forse un aiuto naturale quello che viene meglio tollerato.

L’ultimo gruppo è un rimedio per le conseguenze dei frutti di questo meraviglioso benessere di cui quasi tutti godiamo.

Colesterolo, trigliceridi e ipertensione: credo che sia fantastico avere argomenti validi contro questi malanni che relamente fanno paura a tante persone.

Lo studio che segue nasce dunque dalla mia curiosità e dalle informazioni di esperienze e studi approfonditi di Laboratori di Ricerca e Case Farmaceutiche di cui mi sono avvalsa.

Fonti

Bibliografia

Rhodendron caucasicum
  1. Z. Ramazanov, M. del Mar Bernard Suarez (1999) -Effective natural stress and weight management using Rhodiola rosea and Rhododendron caucasicum,ATNS/Safe Goods Publishing, p. 1-76,.
  2. Rossiyski MD (1954).Rhododendron-a new remedy for regulation of blood circulation deficiency, Pharmacology and Toxicology, 17, p. 3-12.
  3. Koshihara, Y, Neichi, T., Murota, S.I., Lao A.N., Fujimoto, Y., Tatsuno, T. (1984).Caffeic acid is a selective inhibitor for leucotriene biosynthesis . Biochim. Biophys. Acta, 792, p. 92-96.
  4. Shalashvili A (1967 a.) Method of total flavonoids extraction from Rhododendron caucasicum. Proceedings of Georgian Academy of Science (48) pp 603.
  5. Shalashvili A(1967b) -Flavonoids of Rhododendron caucasicum. Proceedings of Georgian Academy of Science (46) pp 115.
  6. Shalashvili A(1873). Identification of flavonoids in Rhododendron caucasicum. Plant Biochemistry, Vol 1, p. 214.
  7. Durmishidze S.B.,Shalashvili AG, Mshavanadze BB, Tziklauri GC(1981) .Flavonoids and phenilpropanoids in Georgian wild growing plants. Tbilisi, Georgia, p 194.
  8. Brand Williams W, Cuvelier ME, Berset C. (1995) Use of a free radical methodology to evaluate antioxidant activity. Lebesm-wiss and Technol . 28, pp 25-30.
  9. Butler LG (1992).Antinutritional effect of condensed and hidrolizable tannins. Basic Life Sci; 59: 693-698.
  10. Carmona A. Tannins:thermostable pigments which complez dietary proteins and inhibit digestive enzymes. Arch Latinoam Nutr 1996 Dec; 44(4Sppl 1) : 3 1 S-35S.
  11. Griffiths DW (1986). The inibition of digestive enzymes by polyphenolic compounds. Adv Exp Med Biol, 199:509-516.
  12. Gvishiani GC, Litanishvili VB (1955). Rhodogern extract of Rodhodendron in treatements of high blood pressure. Internetional Congress of pathology of cardiovascular systems. Pavlov Institute of Physiology , Leningrad USSR.
  13. Harborne JB, Williams CA (1971).Leaf survey of flavonoids and simple phenols in the genus Rhododendron. Phytochemisrty, 10, 2733.
  14. Horigome T. Kumar R. Okamoto K. (1988).Effects of condensed tannins prepared from leaves of fodder plants on digestive enzymes in vitro and in the intestine of rats. Br J Nutr 60(2):275-285.
  15. Loose R. (1970). Flavonoid-glycosides in the petal of some Rhododendron species and hybrids. Phytochemistry, 9, p. 875.
  16. Zhu M, Phillipson JD , GreengrassPM, BoweryNE, Cai Y. Plant polyphenols: biologically active compounds or non selective binders to protein ? Phytochemistry 1997; 44(3): 441-447.
  17. Samartzev A.D. , Aushev I V, Israelov FR (1965).Effect of Rhododendron caucasicum extract on gout and sodium release in urine. Russian Clinical research, Dagestan State Hospital annual report, Dagestan Scientific Publisher, p112.
  18. Humphreys and Stodulski (1985). Detection of Andromedotoxins for the diagnosis of Rhododendron Poisoning in animals. Pathology Departement, The Royal Veterinary College, Royal College, London NW
Rhodiola rosea
  1. Germano C, Ramanazov Z. Artic Root (Rhodiola rosea): the powerful new ginseng alternative. Kensington Publishing Corp. NY 1999.
  2. Z. Ramanazov, M. del Mar Bernard Suarez (1999) - Effective natural stress and weight management using Rhodiola rosea and Rhododendron caucasicum, ATNS/Safe Goods Publishing East Canaan, Connecticut.
  3. Furmanova M, Kedzia B, et al. Phytochemical and Pharmacological properties of Rhodiola rosea L. Herba Polonica. Tom XLV 1999 Nr 2.
  4. Petkov V.D., et al. Effects of Alcohl Acqueous Extract from Rhodiola rosea L. Roots on Learning and Memory. Acta Physiologica et pharmacologica bulgarica, Vol 12, No 1, p.315. Sofia 1986.
  5. Kurkin VA, Zapesochnaya GG (1986) The chemical composition and pharmacological properties of plants of the genus Rhodiola J Med Plants (Moskow) Vol 20 pag 1231-1244
  6. Saratikov, A S (1973). The Gold Root (Rhodiola rosea). Publ. By the Tomsk University. Tomsk, p124.
  7. Thieme H (1969) Ober lie Identitad der Glykoside Rhodiolosid und Salidrosid. Pharmazie, 24, 118-119.
  8. Wagner, H, Norr H, Winterhoff H. Plant Adaptogens. Phytomedicine, 1, 63-76, 1994.
  9. Breckham II, Dardymov IV. New substances of plant origin which increase non specific resistance. Ann Rev Phar-macol., 419-430, 1969.
  10. Spasov AA, Wikman GK, et al. A double blind, placebo controlled pilot study of the stimulating and adaptogenic effect of Rhodiola roses SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, Vol 7(2) 2000, pp. 85-89.
  11. Krasik ED, Morosov EC, PetrovaKP. 1970 A new results on therapy of depression and depressive conditions. Perspectives of clinical application of Rhodiola rosea extract. In “Current Problems of psycho-pharmacology. Kemerovo, USSR. pp. 298-300.
  12. Krasik ED, Petrova KP., Rogulina GA, 1970. To adaptive and stimulative effect of Rhodiola rosea extract. In “Proceedings of USSR Congress in neuro-pathology, neuro surgery, and psychiatry. Sverdlovsk, May 26-29, 1970, pp. 215-217. Saratikov AC.,Marina TF., Kaliko IM 1965. Stimulative effect of Rhodiola rosea extract on brain function. Proceedings of USSR Academy of Sciences, Siberian Branch. Medico-Biological Department. Vol. 8, 2: 120-125.
  13. Krasik ED, Petrova KP., Rogulina GA, 1970. To adaptive and stimulative effect of Rhodiola rosea extract. In “Proceedings of USSR Congress in neuro-pathology, neuro surgery, and psychiatry. Sverdlovsk, May 26-29, 1970, pp. 215-217.
  14. Saratikov and Krasnov, 1986. Rhodiola rosea- valuable medicinal plant: Golden root, Tomsk, Institute of Pharmacology, Tomsk Medicinal center, Academy of Sciences. pp 217-227 Chapter VIII “Clinical research of Rhodiola rosea”.
  15. Saratikov and Krasnov, 1986. Rhodiola rosea- valuable medicinal plant: Golden root, Tomsk, Institute of Pharmacology, Tomsk Medicinal center, Academy of Sciences. pp 69-89, Chapter III “Stimulative characteristics ofRhodiola rosea”.
  16. Abodoff MT 1997. Stimulative effect of Rhodiola rosea extract on fatty acid release in healthy volunteers. Clinical study for Russian Ministry of Health. Special report (available upon request on confidential basis).
  17. Dr. Professor Irakly Chkkhikvishvili 1998. Rhodiola rosea and weight reduction, ITA Ltd clinical studies, Presented to Georgian Health Ministry, available upon request.
  18. Saratikov AS and Tuzov SF, 1963. Effect of rhaponticum carthamoides on physical performance and other physiological parameters of athletes. Proceedings of USSR Academy of Sciences, Biology and Medicine, Vol. 12, N-3, pp.126-132;
  19. Saratikov and Krasnov, 1987. Rhodiola rosea- valuable medicinal plant: Golden root, Tomsk, Institute of Pharmacology, Tomsk Medicinal center, Academy of Sciences. pp 1-14, Chapter VI “The influence of Rhodiola rosea on the endocrine glands and the liver ”.
  20. Zotov MI, Krilov GB, Saratikov AS, 1965. Toxicity of Rhodiola rosea, Proceedings of Siberian Academi of Sciences, Vol, 2 N 8 pp 111-119.
  21. Akeseneva PA et al. 1968. Published in Stimulators of Central Nervous System, Tomsk, Vol. 1, pp 77-79, Russia.
  22. Poli A, Valla C, 2000. Estratti secchi una questione di qualità ed attività: il caso della Rhodiola rosea. Integratore Nutriz. In pubblicazione sul numero di gennaio 2001.
  23. Barnaulov OD, Limarenko AU, Kurkin VA (1965). Neurotropic and adaptogenic effect of Rhodiola rosea. Chemical and Pharmaceutical Journal, Moscow, N. 9, pp. 1107-1112.
  24. Marina TF, Krasnov EA, Saratikov AS (1983). Problems of medicinal plants resources of Siberia and Russian Far East. Novosibirsk, Russia, pp 129-131.
  25. Sokolov S, Ivashin VM, Zapesochniaya GG (1985). Comparative analysis of pharmacological activity of salidroside and rosavin. Chemical and Pharmaceutical Journal, Moscow, Vol 19, N. 11, pp 1367-1371.
  26. Wang S, Wang FP. (1992). Studies on the chemical components of Rhodiola crenulata. Yao Hsueh Pao 27(2):117-20.
  27. Peng JN, Ma CY, Ge YC (1994). Chemical constituents of Rhodiola kirilowii (Regel) Regel. Chung Kuo Chung Yao Tsa Chih Nov 19(11):676-7, 702
  28. Yoshikawa M, Shimada H, Shimoda H, Murakami N, Yamahara J, Matsuda H (1996). Bioactive constituents of Chinese natural medicines. II. Rhodiola radix (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifolia (Pall) Fisch. Et Mey. Chem Pharm Bull (Tokyo) Nov; 44(11):2086-91.
  29. Kurkin VA, Zapesochnaya GG, Shavlinski AN (1985) Method of identification of Rhodiola rosea root Chem Pharmaceut J (Moskow) 3 185-190
  30. Komar VV, Karpliuk ZV, Kit SM, et al. (1980). Macro and micronutrient composition of root extracts of Rhodiola rosea. Farm Zh. Jun (3):58-60.
  31. Yoshikawa M, Shimada H, Shimoda H, Matsuda H, Yamahara J, Murakami N. (1995). Rhodiocyanosides A and B, new antiallergic cyanoglycosides from Chinese natural medicine “si lie hong jing tian”, the underground part of Rhodiola quadrifida (Pall) Fisch et Mey. Chem Pharm Bull (Tokyo), Jul; 43(7):1245-7
  32. Kurkin VA, Zapesochnaya GG, Shavlinski AN (1984) Flavonoids of aerial parts of Rhodiola rosea Chem Nat Prod5632-636
  33. Azizov AP, Seifulla RD (1998) The effect of elton, leveton, fitoton and adapton on the work capacity of experimental animals Exp Clin Pharmacol61(3)61-63
Naringina
  1. Maish WA, Hampton EM, Whitsett TL, Shepard JD, Lovallo WR (1996). Influence of grapefruit juice on caffeine pharmacokinetics and pharmacodynamics. Pharmacotherapy 16(6):1046-52.
  2. Fuhr U, Klittich K, Staib AH (1993). Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35(4):431-6.
  3. Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH (1995). Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 33(6):311-4.
  4. Medicamenta. Ed VI. Scuole grafiche Pavoniane Artigianelli. Milano, Ed su Cd-rom.
  5. Ross SA, Ziska DS, Zhao K, ElSohly MA (2000). Variance of common flavonoids by brand of grapefruitjuice. Fitoterapia 71(2):154-61.
  6. Manthey JA, Grohmann K (2001). Phenols in citrus peel byproducts: concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. J Agric Food Chem. 49(7):3268-73.
  7. Ho PC, Saville DJ, Coville PF, Wanwimolruk S (2000). Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharm Acta Helv 74(4):379-85.
  8. Pedretti M. Chimica e farmacologia delle piante medicinali. Studio Edizioni. Milano, 1997. p. 47-48.
  9. Martin MJ, Marhuenda E, Perez Guerrero C, Franco JM (1994). Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology 49(3):144-50.
  10. Borrelli F, Izzo AA (2000). The plant kingdom as a source of anti-ulcer remedies. Phytother Res 14(8):581-91.
  11. Lee CH, Jeong TS, Choi YK, Hyun BH, Oh GT, Kim JR, Han JI, Book SH (2001). Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic acat and aortic vcam-1 and mcp-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun. 284(3):681-8.
  12. Gordon PB, Holen I, Seglen PO (1995). Protection by naringin and some other flavonoids of hepatocytic autophagy and endocytosis against inhibition by okadaic acid. J Biol Chem 270(11):5830-8.
  13. Blankson H, Grotterod EM, Seglen PO (2000). Prevention of toxin induced cytoskeletal disruption and apoptotic liver cell death by grapefruit flavonoid, naringin. Cell Death Differ 7(8):739-46.
  14. Bear WL, Teel RW (2000). Effect of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Res. 20(5B):3609-14.
  15. Bear WL, Teel RW (2000). Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res 20(5A)3323-9.
  16. Ueng YF, Chang YL, Oda Y, Park SS, Liao JF, Lin MF, Chen CF (1999). In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver. Life Sci 65(24):2591-602.
  17. Fukada K, Ohta T, Yamazoe Y (1997). Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non flavonoid components in drug interaction. Biol Pharm Bull. 20(5):560-4.
  18. Fuhr U, Kummert AL (1995). The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther. 58(4):365-73.
  19. Kim DH, Jung EA, Sohng IS, Han JA, Kim TH, Han MJ (1998). Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 21(1):17-23.
  20. Ishii K, Furuta T, Kasuya Y (1997). Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J Chromatogr B Biomed Sci Appl. 704(1-2):299-305.
  21. Lee YS, Reidenberg MM (1998). A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man. Pharmacology 56(6):314-7.
  22. Kuo SM, Levitt PS, Lin CP(1998). Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol Trace Elem Res. 62(3):135-53.
  23. Bourian M, Runkel M, Krisp A, Tegtmeier M, Freudenstein J, Legrum W (1999). Naringenin and interindividual variability in interaction of coumarin with grapefruit juice. Exp Toxicol Pathol 51(4-5):289-93.
  24. Evans AM (2000). Influence of dietary components on the gastrointestinal metabolism and transport of drugs. The Drug Monit. 2281):131-6.
  25. Bailey DG, Arnold JM, Munoz C, Spence JD (1993). Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther. 53(6):637-42.
  26. Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD (1993). Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther. 54(6):589-94.
  27. Runkel M, Tegtmeier (1996). Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in men. Eur J Clin Pharmacol 50(3):225-30.
  28. Draper AJ, Madan A, Parkinson A (1997). Inhibition of coumarin 7-hydrolase activity in human liver microsomes. Arch Biochem Biophys. 1; 341(1):47-61.
  29. Ameer B, Weintraub RA (1997). Drug interactions with grapefruit juice. Clin Pharmacokinet. 33(2):103-21.
  30. Fuhr U, Maier-Bruggemann A, Blume H, Muck W, Unger S, et al (1998). Grapefruit juice increases oral nimodipine bioavailability. Int J Clin Pharmacol Ther. 36(3):126-32.
  31. Bailey DG, Malcolm J, Arnold O, Spence JD (1998). Grapefruit juice-drug interactions. Br J Clin Pharmacol. 46(2):101-10.
  32. Curhan GC, Willett WC, Rimm EB, et al (1996). Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 143:240-247.
  33. Curhan GC, Willett WC, Speizer FE, et al. (1998). Beverage use and risk for kidney stones in women. Ann Intern Med. 128:534-540.
  34. Bratman S (2001). The Natural Pharmacist: Natural Health Bible, Revised and Expanded 2nd edition Edited by Stepven Bratman, M.D. & David Kroll, PhD 2001. CD-rom.
  35. Werbach, M. (1993). Healing with Food. Harper Collins, New York, 443 pp
  36. Duke J A. Phytochemical Database. USDA-ARSA-NGRL, Beltsville Agricultural Research Center, Beltsville, Maryland (USA). 2001 Edition. Available on request.
  37. Andrich Vince (2001). Sport Supplement review, 4th Issue, Mile High Publishing P.O. box 277 Golden, Co Usa 80402, pag 120.
Melograno
  1. Del Rio MJ. Pomgranade extract: the fruit of healthy cholesterol and longevity. Nutraceutical world. March 2001, pag 122.
  2. Duke J A. Phytochemical Database. USDA-ARSA-NGRL, Beltsville Agricultural Research Center, Beltsville, Maryland (USA). 2001 Edition. Available on request.
  3. Pedretti M. Chimica e farmacologia delle piante medicinali. Studio Edizioni. Milano, 1997. p. 57-58.
  4. Nasr BC, Ayed N, Metche M (1996) Quantitative determination of the polyphenolic content of pomegranate peel. Z. Lebensm Unters Forsch, 203(4): 374-8.
  5. Moneam NM, el Sharaky AS, Badreldin MM (1988) Oestrogen content of pomegranate seeds.J Chromatogr 22; 438(2): 438-42.
  6. Kaul A, Khanduja KL (1998) Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals. Nutr Cancer; 32(2): 81-5.
  7. Lesca P (1983) Protective effects of ellagic acid and other plant phenols on benzo(a)pyrene-induced neoplasia in mice. Carcinogenesis 4(12):1651-1653
  8. Khanduja KL, Gandhi RK, Pathania V, Syal N (1999) Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol; 37(4): 313-8.
  9. Mandal S, Stoner GD (1990) Inhibition of N-nitrosobenzyl-methylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11 (1):55-61
  10. Siglin, JC, Barch D, Stoner GD (1995) Effects of phenethyl isothiocyanate, ellagic acid, sulindac and and progression of esophageal carcinogenesis in rats induced by short-term administration of N-nitrosomethylbenzylamine. Carcinogenesis 16(5) 1101-6.
  11. Nepka C, Asprodini E, Kouretas D (1999). Tannins, xenobiotic metabolism and cancer chemo-prevention in experimental animals. European Journal of drug metabolism and pharmacocinetics, Vol 24, No 2, pp 183-189.
  12. Das M, Bickers DR, Mukhtar H (1985). Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of anticancerogenic action. Carcinogenesis, 6(10):1409-1413.
  13. Barch DH, Fox CC (1988). Selective inhibition of metrhylbenzylnitrosamine-induced formation of esophageal O6-methylguanine by dietary ellagic acid inrats. Cancer Res, 48 (24 Pt 1):7088-7092.
  14. Stoner GD, Mukhtar H (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem, 22 (Suppl): 169-180.
  15. Majid SM, Khanduja KL, Gandhi RK, Kaopur S, Sharma RR (1991). Influence of ellagic acid on antioxidant defence system and lipid peroxidation in mice. Biochem. Pharmacol. 42(7): 1441-1445.
  16. Thresiamma KC, Kuttan R (1996). Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol. 40(4):363-366.
  17. Prashanth D, Asha MK, Amit A (2001). Antibacterial activity of Punica granatum. Fitoterapia 72(2):171-3.
  18. Anesini C, Perez C (1993). Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol 39(2):119-28.
  19. Perez C, Anesini C (1994). In vitro antibacterial activity of Argentine folk medicinal plants against Salmonella typhi. J Ethnopharmacol 44(1):41-6.
  20. Zhang J, Zhan B, Yao X, Gao Y, Shong J. (1995). Antiviral activity of tannin from the pericarp of punica granatum L against genital Herpes virus in vitro. Zhongguo Zhong Yao Za Zhi 20(9):556-8.
  21. Navarro V, Villarreal ML, Rojas G, Lozoya X (1996). Antimicrobial evaluation of some plants used in Mexican traditional medicine for the treatment of infectious diseases. J Ethnopharmacol 53(3):143-7.
  22. Morsy TA, Mazyad SA, el-Sharkawy IM (1998). The larvicidal activity of solvent extracts of three medicinal plants against third instar larvae of Chrysomyia albiceps. J Egypt Soc Parasitol. 28(3):699-709.
  23. Dutta BK, Rahman I, Das TK (1998). Antifungal activity of Indian plant extracts. Mycoses 41(11-12):535-6.
  24. Raj RK (1975). Screening of indigenous plants for anthelmintic action against human Ascaris lumbricoides: Part-II. Indian J Physiol Pharmacol Jan-Mar 19 (1).
  25. Tripathi SM, Singh DK (2000). Molluscicidal activity of Punica granatum bark and Canna indica root. Braz J Med Biol Res 33(11):1351-5.
  26. Schubert SY, Lansky EP, Neeman I (1999). Antioxidant and eicosanoid enzyme inhibition properties of pomgranate seed oil and fermented juice flavonoids. J Ethnopharmacol 66(1):11-7.
  27. Gharzouli K, Khennouf S, Amira S (1999). Effects of aqueous extracts from Quercus ilex L. root bark, Punica granatum L. fruit peel and Artemisia herba-alba Asso leaves on ethanol-induced gastric damage in rats. Phytother Res. 13(1):42-5.
  28. Das AK, Mandal SC, Banerjee SK, Sinha S, Das J, Saha BP, Pal M (1999). Studies on antidiarrhoeal activity of Punica granatum seed extract in rats. J Ethnopharmacol 68(1-3):205-8.
  29. Prashanth D, Padmaja R, Samiulla DS (2001). Effect of certain plant extracts on alpha-amylase activity. Fitoterapia. 72(2):179-81.
  30. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000). Pomgranade juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 71(5): 1062-76.
  31. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000) Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation. 101(21): 2510-7
  32. Aviram M (1999). Does paraoxonase play a role in susceptibility to cardiovascuklar disease ? Molecular Medicine Today. September 1999 (Vol 50) p381-386.
  33. Jimenez Misas CA, Rojas Hernandez NM, Lopez Araham AM (1979). Biological evaluation of Cuban plants IV. Rev Cubana Med Trop. 31(1):29-35.
  34. Cai L, Wu CD (1996) Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.J Nat Prod, 59(10): 987-90.
  35. Segura JJ, Morales Ramos LH, Verde Star J, Guerra D (1990). Growth inhibition of Entamoeba histolytica and E. invadens produced by pomgranade root (Punica granatum L.). Arch Invest Med (Mex). 21(3):235-9.
  36. Shahidi F, Wanasundara PD, Hong C (1992) Antioxidant activity of phenolic compounds in meat model system. In: Phenolic compounds in food and their effect of health. ACS Symposium, Series 506 Washington DC, pp. 214-222.
  37. Medicamenta. Ed VI. Scuole grafiche Pavoniane Artigianelli. Milano, 1976. Vol quarto, pag. 3613-14.
Luteina
  1. Di Mascio P., Devasagayam TP., Kaiser S., Sies H. Carotenoids, tocopherols and thiols as biological singlet molecular oxygenquenchers. Biochem. Soc. Trans. 1990; 18(6) : 1054-6.
  2. Krinsky NI, Deneke SM. Interaction of oxygen and oxy-radicals with carotenoids. J. Natl. Cancer Inst. 1982 ; 69(1) : 205-10.
  3. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and degerenerative diseases of aging. Proc. Natl. Acad. Sci. 1993 90: 7915-7922.
  4. Rock Cl , Saxe GA, Ruffin MT,, et al. Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr. Cancer 1996; 25:281-296.
  5. Khachik F, Beecher GR, Smith JC Jr. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem Suppl . 1995 ; 22: 236-46
  6. Howard AN, WilliamsNr,Palmer CR, etal. Do hydroxy-carotenoids prevent coronary heart desease? A comparison between Belfast and Tolouse. Int J Vitam Nutr Res 1996; 66: 113-8.
  7. Morris DL, Kritchevsky SB, Davis CE. Carotenoids and coronary heart desease. The lipid Research Clinics Coronary Primary Prevention Trial and follow-up Study. J.A.M.A. 1994 ;272: 1434-41.
  8. VandenLangenberg GM, Brady WE, Nebeling LC, Blok G, Forman N, Bowen PE, Stacewicz-Sapuntzakis M, Mares-Perlman JA. Influence of using different sources of carotenoid data in epidemiologic studies. J. Am. Diet. Assoc. 1996; 96(12) : 1271-5.
  9. Pratt S. Dietary prevention of age- related macular degeneration. J Am Optom Assoc 1999; 70: 39-47.
  10. Seddon J.M., Ajani U.A.,Sperduto R.D., etal. Dietary carotenoids, vit A, C, and E, and advanced age-related macular degeneretion. J.A.M.A. 1994; 272: 1413-20
  11. Landrum J,Bone RA, Joa H, Kilburn MD, Moore LL,Sprague KE. A one year study of the macular pigment the effect of 140 days of a lutein supplement. Exp. Eye. Res 1997; 65(1) : 57-62.
  12. Hankinsons SE., Stampfer M.J., et al. Nutrient intake and cataractextration in women: a prospective study. B.M.J. 1992; 305: 335-9.
Polygonum Cuspidatum

1 . Fremont L Biological effect of resveratrol. Life Sci 66, 663-73, 2000.

  1. Kimura, Y., Okuda, .., Kubo, M. Effectsof stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclearleukocytes. J. Ethnopharmacol, 45, 131-139 , 1995.
  2. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol . Lancet, 341, 1103-1104,1993.
  3. Jang M., Cai L., G.O. Udeani.Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220, 1997.
  4. Jayatilake G.S., Jayasuriya H., E.S., Koonchanok N.M., Geahln R.L., Ashendel C.L., McLaughlin J.K. Chang C.J.,Kinase inhibitors from Plygonum cuspidatum. J. Nat. Prod., 56, 1805-1810, 1993.
  5. Jayasuriya H., Koonchanok N.M., Geahlen R.L., McLaughlin J.L.,Chang C:J.Emodin A protein tyrosine Kinase inhibitor from Polygonum Cuspidatum. J. Nat. Prod., 55, 696-698, 1992.
  6. Martinez J., Moreno J.J.,Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59, 865-70, 2000.
Maca
  1. Rea J. Raices andinas: maca in Bermejo, H. and Leon, . 10. , eds., Cultivos marginados, otra perspectiva de 1492.1992
  2. King S.,”Ancient Buried Treasure of the Andes” , Garden, November/December.1986
  3. National Research Counsil Report of an Ad Hoc panel of the advisory commitee on thecnical innovation, board on science and technology for internationaldevelopement, Lost crops of the Incas : little known plants of the Andes with promise for worldwide cultivation, 1989
  4. Johns T. The anu and the Maca. Journal of Ethnobiology .1981 1: 208-212
  5. Quiros C.Et al.,Physiological studies and determination of chromosome number in Maca, Lepidium meyenii. Economic Botany. 1996, 50(2), 216-223.
  6. Gomez A. , Maca Es alternativa nutricional para el ano 2000. Informe Ojo con su salud No. 58 August 15, 1997, Lima Perù.
  7. Steinberg P. Phil Steinberg’s Cat’s claw News, 1995, Vol. 1 , Issue, July/August.
  8. Zheng B. L., He K., Kim C. H., Rogers L., Shao Y., Huang Z. Y., Yan S. J., Qien L. C., Zheng Q. Vol. 1 , Issue, July/August.
  9. Zheng B. L., He K., Kim C. H., Rogers L., Shao Y., Huang Z. Y., Yan S. J., Qien L. C., Zheng Q. . Effect of a lipidic extract from lepidim meyenii on sexual behaviour in mice and rats. Urology. 2000 Apr., 55(4) : 598-602.
  10. Chacon R. C.Estudio fitoquimico de Lepidiu meyenii. Dissertation, Univ., Nac. Mayo de San Marcos, 1961, Perù.
Fitosteroli da olio di palma
  1. Ebong P.E., Owu DU, Isong EU.Influence of palm oil (Elaesis guineensis) on health.Plant Foods Hum Nutr 53(3):209-22, 1999.
  2. Jones PJ. Cholesterol-Lowering Action of Plant Sterols. Atheroscler Rep. 1, 230-235,1999.
  3. Plat J, Kerckhoffs DA, MensinkRP.Therapeutic potential of plants sterols and stenols. Curr Opin Lipidol. 11 (6) , 571-6, 2000.
  4. Miettinen TA, Gylling H, Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis. 153 (1) : 241-8, 2000.
  5. Vissers MN, Zock PL, Meiyer GW, Katan MB.Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans. Am. J Clin Nutr. 72, 1510-5 , 2000.
  6. Weststrate J. Functional foods: cholesterol-lowering benefits of plants sterols. Br J Nutr. 84 (2) : 252-4, 2000.
  7. Visioli F, Borsani L , Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals . Cardiovasc Res 18; 47(3) : 419-25, 2000.
  8. Awad AB, Downie A, Fink CS, Kim U.Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res. 20(2A): 821-4, 2000.
  9. Awad AB, Fink CS,Phitosterols as anticancer dietary components: evidence and mechanism of action. Nutr. 130(9) , 2127-30, 2000.
  10. Awad AB, Gan Y, Fink CS.Effect of beta-sitosterol, a plant sterol, on growth, protein phosphatase 2A, and phospholipase D in LNCaP cells. Nutr Cancer. 36(1), 74-8, 2000.
L’Andrographis paniculata
  1. Bratman S. Natural Health Bible. Edited by Stepven Bratman, M.D. & David Kroll, PhD 1999, p 123-124.
  2. Hancke J, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvements in the recovery from common colds. Phytotherapy Res 9:559-562, 1995.
  3. Caceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK. Use of visual analogue measurments (VAS) to assess the efectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A random double blind-placebo study. Phytomedicine 1999 Oct; 6(4):217-23.
  4. Melchior J, Spasov AA, Ostrovskij OV, Bulanov AE, Wickman G. Double-blind, placebo-controlled pilot study and phase III study of activity of standardized Andrographis paniculata Herba Net extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection. Phytomedicine 2000 Oct; 7(5):341-50.
  5. Thamlikitkul V, Dechatiwongse T, Theerapong S, Chantrakul C, Be P, Punkrut W, Ekpalakorn W, Boontaeng N, Taechaiya S, et al. Efficacy of Andrographis paniculata, Ness for pharyngotonsillitis in adults. J Med Assoc Thai. 1991 Oct; 74(10):437-42.
  6. Shen YC, Chen CF, Chiou WF. Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med 2000 May; 66(4):314-7.
  7. Puri A, Saxena R, Saxena KC, Srivastava V, Tandon JS. Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993 Jul; 56(7):995-9.
  8. Dutta A, Sukul NC. Filaricidal properties of a wild herb, Andrographis paniculata. J Helminthol 1982 Jun; 56(2):81-4.
  9. Mehrotra R, Rawat S, Kulshreshtha DK, Patnaik GK, Dhawan BN. In vitro studies on the effect of certain natural products against hepatitis B virus. Indian J Med Res 1990 Apr; 92:133-8.
  10. Leelarasamee A, Trakulsomboon S, Sittisomwong N. Undetectable anti-bacterial activity of Andrographis paniculata (Burma) wall.ex ness. J Med Assoc Thai 1990 Jun; 73(6):299-304.
  11. Chang RS, Ding L, Chen GQ, Pan QC, Zhao ZL, Smith KM. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 1991 May; 197(1):59-66.
  12. Najib Nik A Rahman N, Furuta T, Kojima S, Takane K, Ali Mohd. J Ethnopharmacol 1999 Mar; 64(3):249-54.
  13. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, et al. A phase I trial of andrographolide in HIV positive patientsand normal volounteers. Phytother Res 2000 Aug; 14(5):333-8.
  14. Zhao HY, Fang WY. Protective effects of andrographis paniculata nees on post-infarction myocardium in experimental dogs. J Tongji Med Univ 1990; 10(4):212-7.
  15. Zhao HY, Fang WY. Antithrombotic effects of Andrographis paniculata nees in preventing myocardial infarction. Chin Med J (Engl) 1991 Sep; 104(9):770-5.
  16. Wang DW, Zhao HY. Experimental studies on prevention of atherosclerotic arteriostenosis and restenosis after angioplasty with Andrographis paniculata Nees and fish oil. J Tongji Med Univ 1993; 13(4):193-8.
  17. Zhang CY, Tan BK. Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J Ethnopharmacol 1997 Apr; 56(2):97-101.
  18. Zhang CY, Tan BK. Hypotensive activity of aqueous extract of Andrographis paniculata in rats. Clin Exp Pharmacol Physiol 1996 Aug; 23(8):675-8.
  19. Guo ZL, Zhao HY, Zheng XH. The effect of andrographis paniculata nees (APN) in alleviating the myocardial ischemic repurfusion injury. J Tongji Med Univ 1994;14(1):49-51.
  20. Guo Z, Zhao H, Fu L. Protective effects of API0134 on myocardial ischemia and repurfusion injury. J Tongji Med Univ. 1996; 16(4):193-7.
  21. Chiou WF, Lin JJ, Chen CF. Andrographolide suppresses the expression of indicible nitric-oxide synthase in macrophage and restores the vasoconstric rat aorta treated with lipopolysaccharide. Br J Pharmacol 1998 Sep; 125(2):327-34.
  22. Zhang C, Kuroyangi M, Tan BK. Cardiovascular activity of 14-deoxy-11,12-didehydroandrographolide in the anaesthetised rat isola right atria. Pharmacol Res 1998 Dec; 38.
  23. Wang HW, Zhao HY, Xiang SQ. Effects of Andrographis paniculata component on nitric oxide (NO), endothelin and lipid peroxidation in experimental atherosclerotic rabbits. Zhongguo Zhong Xi, Jie He Za Zhi, 1997 Sept; 17(9):547-9.
  24. Amroyan E, Gabrielian E, Panossian A, Wikman G, Wagner H. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 1999 Mar; 6(1):27-31.
  25. Zhang YZ, Tang JZ, Zhang YJ. Study of Andrographis paniculata extracts on antiplatelet aggregation andrelease reaction and its mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi 1994 Jan; 14 (1):28-30, 34, 35.
  26. Wang DW, Zhao HY. Prevention of atherosclerotic arterial stenosis and restenosis angioplasty with Andrographis paniculata nees and fishoil. Experimental studies of effects and mechanisms. Chin Med J (Engl) 1994 Jun; 107(6):464-70.
  27. Choundhury BR, Poddar MK. Andrographolide and kalmegh (Andrographis paniculata) extract: effect on intestinal brush-border membrane-bound hydrolases. Methods Find Exp Clin Pharmacol 1985 Dec; 7(12):617-21.
  28. Iinuma M, Tanaka T, Mizuno M, Katsuzaki T, Ogawa H. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase. Chem Pharm Bull (Tokyo) 1989 Jul; 37(7):1813-5.
  29. Zhang XF, Tan BK. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol 2000 May-Jun; 27(5-6):358-63.
  30. Borhanuddin M, Shamsuzzoha M, Hussain AH. Hypoglycaemic effects of Andrographis paniculata Nees on diabetic rabbits. Bangladesh Med Res Counc Bull 1994 Apr 20.
  31. Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielan E, Goukasova G, Wikman G, et al. Pharmacokinetic and bioavailability of andrographolid of Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 2000 Oct; 7(5):351-64.
  32. Rana AC,Avadhoot Y. Hepatoprotective effects of Andrographis paniculata against carbon tetrachloride-induced liver damage. Arch Pharm 1991 Mar; 14(1):93-5.
  33. Visen PK, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracethamol induced damage. J Ethnopharmacol 1993 Oct; 40(2):131-6.
  34. Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol 1993 Jul 6; 46(1):182.
  35. Shukla B, Visen PK, Patnaik GK, Dhawan BN. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med 1992 April; 58(2):146-9.
  36. Handa SS, Sharma A. Hepatoprotective activity of andrographolide against galactosamine & paracetamol intoxication in rats. Indian J Med Res 1990 Aug; 92:284-92.
  37. Choudhury BR, Poddar MK. Andrographolide and kalmegh (Andrographolide paniculata) extract: in vivo and in vitro effect on hepatic lipid peroxidation. Methods Find Exp Clin Pharmacol 1984 Sep;6(9):481-5.
  38. Zoha MS, Hussain AH, Choudhury SA. Antifertility effect of andrographis paniculata in mice. Bangladesh Med Res Counc Bull 1989 Jun; 15(1):34-7.
  39. Akbarsha MA, Manivannan B, Hamid KS, Vijayan B. Antifertility effect of Andrographis paniculata (Nees) in male albino rat. Indian J Exp Biol 1990 May; 28(5):421-6.
  40. Burgos RA, Cabalero EE, Sanchez NS, et al. Testicular toxicity assessment of Andrographis paniculata extract in rats. J Ethnopharmacol 1997 Nov; 58(3):219-24.
  41. Panossian A, Kochikian A, Gabrielian E, Mradian R, Stepanian H, et al. Effect of Andrographis paniculata extract on progesterone in blood plasma of pregnant rats. Phytomedicine 1999 Jul; 6(3):157-61.
  42. Burgos RA, Imilan M, Sanchez NS, Hancke JL. Andrographis paniculata (Nees) selectively blocks voltage.operated calcium channels in rat vas deferens. J Ethnopharmacol 2000 Jul; 71(1-2):115-21.
  43. Akbarsha MA, Murugaian P. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effects on the test of the cauda epidymidal spermatozoa. Phytother Res 2000 Sep; 14(6):432-5.
Withania somnifera
  1. Bratman S. Natural Health Bible. Prima Health by Prima Publishing, USA, 1999, p. 128.
  2. Singh N, Nath R, Lata A et al. Withania somnifera (ashwaganda), a rejuvenating herbal drug which enhances survival during stress (an adaptogen). Int J Crude Drug Res 1982; 20:29-35.
  3. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants, Vol 6. Central Drug Research Institute, New Delhi, 1998.
  4. Bhattacharya SK, Goel RK, Kaur, Ghosal S. Antistress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytotherapy Res 1987; 1:32-39.
  5. Dadkar VN, Ranadive NU, Dhar HL. Evaluation of antistress (adaptogen activity of Withania somnifera (ashwaganda). Ind J Clin Biochem 987; 2:101-108.
  6. Archana R, Namasivayan A. Antistressor effect of Withania somnifera. J Ethnopharmacol 1999; 64:91-93.
  7. Lakshmi-Chandra Mishra MD, Betsy B Singh, Simon Dagenais BA. Scientific Basis for the Therapeutic Use of Withania somnifera (Ashwagandha): A Review. Alternative Medicine Review Vol. 5 n. 4 Aug 2000.
  8. Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 1997;35:297-299.
  9. Malhotra CL, Mehta VL, Das PK, Dhalla NS. Studies on Withania-ashwagandha, Kaul. V. The effect of total alkaloids (ashwagandholine) on the central nervous system. Indian J Physiol Pharmacol 1965; 9:127-136.
  10. Malhotra CL, Mehta VL, Prased K, Das PK. Studies on Withania-ashwagandha, Kaul IV. The effects of total alkaloids on the smooth muscles. Indian J Physiol Pharmacol 1965; 9:9-15.
  11. Scheliebs R, Liebmann A, Bhattacharya K, et al. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int 1997; 30:181-190.
  12. Malhotra CL, Das PK, Dhalla NS, Prasad K. Studies on Withania ashwagandha, Kaul. III. The effect of total alcaloids on the cardiovascular system and respiration. Indian J Med Res 1981; 49:448-460.
  13. Panda S, Kar A. Evidence for free radical scavenging activity of ashwagandha root powder in mice. Indian J Physiol Pharmacol 1997; 41:424-426.
  14. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J Pharm Pharmacol 1998; 50:1065-1068.
  15. Ghosal S, Lal J, Srivastava R, et al. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytotherapy Res 1989; 3:201-206.
  16. Ziauddin M, Phansalkar N, Patki P, et al. Studies on the immunomodulatory effects of ashwagandha. J Ethnopharmacol 1996 Feb; 50:69-7.
  17. Dhuley JN. Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice J Ethnopharmacol 1997; 58:15-20. 18.Anbalagan K, Sadique J. Influence of an Indian medicine (ashwagandha) on acute-phase reactants in inflammation. Indian J Exp Biol 1981; 19:245-249.
  18. Anbalagan K, Sadique J. Role of prostaglandins in acute phase proteins in inflammation. Biochem Med 1984; 31:236-245.
  19. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross over study. J Ethnopharmacol 1991; 33:91-95.
  20. Somasundaran S, Sadique J, Subramoniam A. In vitro absorption of ī›14 Cī leucine during inflammation and the effect of antiinflammatory drugs in the jejunum of rats. Biochem Med 1983; 29:259-267.
  21. Singh N, Singh SP, Nath R, et al. Prevention of urethane-induced lung adenomas by Withania somnifera (L.). Dunal in albino mice. Int J Crude Drug Res 1986; 24:90-100.
  22. Devi PU, Sharada AC, Solomon FE, Kamath MS. In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol 1992;30:169-172.
  23. Devi PU, Sharada AC, Solomon FE. In vivo growth inhibitoy and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol 1996; 35:95-100.
  24. Venkataraghavan S, Seshadri C, Sundaresan TP, et al. The comparative effect of milk fortified with aswagandha, ashwagandha and punarnava in children a double-blind study. J Res Ayur Sid 1980; 1:370-385.
  25. Davis L, Kuttan G. Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Etnopharmacol 1998; 62:209-214.
  26. Arseculeratne SN, Gunatilaka AA, Panabokke RG. Studies of medicinal plants of Sri Lanka. Part 14: Toxicity of some traditional medicinal herbs. J Ethnopharmacol 1985; 13:323-335.
  27. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol 1994; 44:131-135.
Poterium spinosum
  1. AA. VV.: (1963) Nel mondo della natura- Enciclopedia Motta di Scienze Naturali - Botanica : Vol. VIII p. 427, Ed. Federico Motta- Milano.
  2. Anonimo (1962) “ Selecta” n°I, 15. Selecta- Verlag, Planegg bei Munchen.
  3. Armato G.: (1986) Piante Mediterranee per Giardini , Ed Edagricole - Bologna.
  4. Baisset A. ET al.: (1976) ( per l’azione antiipertensiva e antiaritmica) Thérapie 31, 659.
  5. Blazek Z. :(1968) D.A.Z. N° 38, P. 108.
  6. Budzikiewicz H., Wilson J.M., Djerassi C.,: (1963) J. Amer. Chem. Soc. 85, 3688-3699.
  7. Carraz G., - Boucherle A.,-Dardas A. : (1968) C.R. Acad. Sci. , Paris, Ser. D 266, 293
  8. Cazzuola F., (1876) Dizionario di botanica applicato alla Medicina, alla Farmacia, alla Veterinaria, all’Orticoltura, all’Agricoltura, all’Industria e al Commercio. Ed. Tipografia T. Nistri e CC., Pisa.
  9. Cheung H.T., Yan T.C.:(1970) Chem. Commun., 369-370.
  10. Dunn J.S. and Mc Letchic N.G.B.: (1953) Lancet 245-384.
  11. Durante C. : (1567) Herbario Novo , Ed. GG. Hertz-Venezia.
  12. Fiori A. : (1984) Nuova Flora Analitica d’Italia, Vol. I, Ed. Edagricole- Bologna.
  13. Fiori A-Paoletti G.: (1981) Iconographia Florae Italiae- Flora italiana Illustrata Ed.Edagricole_ Bologna
  14. Gao F., Chen F.H., Tanaka T., kassai R. Seto T., Tanaka O.: (1985) Chem. Pharm. Bull. 33,37.
  15. Gopalsamy N., Vargas D., Gueho J., Ricaud C., Hostettmann K.,:(1988) Phitochemistry 27,3593
  16. Hestrin- Lerner S., and Ben-Yonah S.: (1963) Bull. Res. Conc. Israel 10, 188.
  17. Houghton P.J.- Lian L.M.: (1986) Phitochemistry 25,1939.
  18. Ivorra M.D., et al. : effect of tormentic acid on insulin secretion in isolated rat of Langerhans. Phitoter. Res. 3, 145.
  19. Ivorra M.D., et al. : (1988)Hypoglycemic and insulin release effects of tormentic acid, a new hypoglicemic natural product. Planta M. 54,282.
  20. Jaggy H.,- Kloss P: :(1971) D.A.Z. N° 24 p 111.
  21. Knight S.A. : (1974) Org. Magn. Reson. &, 603-611.
  22. Lazarow A.- Palay S.L. (1946) J. Lab. Clin. Med. 31, 1004.
  23. Menczel E., Mishkinsky J., and Sulman F.G. (1965) Proc. Israel Physiol. Pharmacol. Soc. 1, 47.
  24. Mishinsky J. :(1966) Folia medica (Israel) 25,503.
  25. Mishinsky J.- Menczel E. and Sulman F.G. (1966) Azione ipoglicemizzante su coniglio a 0,2 g/Kg di estratto acquoso Arch. Int. Pharmacodyn. Ther. 161, 306.
  26. Ogunkoya L. :(1981) Phytochemistry 20, 121-126.
  27. Ogura M. Cordell G.A. Farnsworth N.R. : (1977) Lloydia 40, 157-168.
  28. Penzig O. :(1974) Flora Popolare Italiana, Vol. II Ed. Edagricole - Bologna.
  29. Pignatti S. (1982) Flora d’Italia , Vol. Primo, Ed. Edagricole - Bologna.
  30. Piterà F. :(1994) Compendio di Gemmoterapia Clinica (Meristemoterapia ) p. 80 De Ferrari Editore - Genova.
  31. Piterà F. (1996) The role of poterium spinosum as an hypoglicemic agent in the therapy of diabetes mellitus. Atti la Conferenza internazionale di Antropologia e storia della salute e delle malattie. 3° Colloquio Europeo di Etnofarmacologia- Dipartimento di Scienze Atropologiche- Università degli Studi diGenova, 29 maggio- 2 giugno 1996 , Erga EdizioniGenova
  32. Piterà F. :81996) il Ruolo del Poterium spinosum come ipoglicemizzante orale nella cura del diabete mellito Andros, Rivista italiana di Studi e Ricerche sulle medicine Umanistiche Anno I , n°2, pp. 8-17 Erga ed. Genova.
  33. Polunin O. , Huxley A. :(1978) Guida alla Flora Mediterranea, Ed. Rizzoli, Milano.
  34. Polunin O., Walters M . (1985) A guide to the vegetation of Britain and Europe , Oxford University Press, by Oleg Polunin and Martin Walters.
  35. Polunin O. , Walters M. : (1987) Guida alle vegetazioni d’Europa. Ed. Zanichelli, Bologna.
  36. Potier P., Das B.C. , Bui A.M., Janot M.M., Pourrat A., Pourrat H. : (1966) Bull. Soc. Chim. Fr. , 3458 -3465.
  37. Pradhan B.P., De S. Nath A, Schoolery J.N. : (1984) Phytochemistry 23, 2593- 2595.
  38. Quisenberry T.M. Gjerstad G. :(1967) Attività in diabetici ma non in normoglicemici, Quart. J. Crude Drug Res. 7,957.
  39. Reher G. :(1988) Assegnazione di attività ipoglicemizzante a tormentoside, Dtsche Apoth. Ztg. 1281354.
  40. Reher G., Reznicek G., Baumann A. : (1991) Triterpenoids from Sarcopoterium spinosum and Sanguisorba minor. Planta Med. , Phitochemical Notes , 57, 506.
  41. Reher G., Reznicek G., und Robien W. :Drei Triterpene aus Sarcopoterium und Sanguisorba minor.PB 48-758.
  42. Reutter L., (1923) Traité de matière Médicale et de Chimie Végétale , Ed. Librairie J.B. Baillière et fils - Paris. 43.Rucker G., Mayer R., Shin-Kim J.S. (1991) Planta Medica , 57,468. 44.Schluetz G.O.- Venulet J. :(1963) Bioch. Pharmacol. 12 (Supp.) , 274.
  43. Schluetz G.O.- VenuletJ. :(1964) Expirientia 20, 78. 46.Schhonfelder P.e I. :(1984) Die Kosmos Mittelmeerflora , Ed. Franckh’sche Verlagshanddluung, W. Keller Co., Stuttgard.
  44. Schhonfelder P.e I.(1996) La flora mediterranea , Ed. Istituto Geografico De Agostini - Novara.
  45. SETO t., Tanaka T., Tanaka O. , Naruhashi N. : (1984) Phytochemistry 23 ,2829.
  46. Shani J. (Mishkinsky), Joseph B.-Sulman F.G..: Fluttuations in the Hypoglycaemic Effect of Poterium spinosum L. (Rosaceae). Departmebt of Applied Pharmacology, School of Pharmacy , Hebrew University , Jerusalem ,Israel.
  47. Shigenaga S.-Kuono I.-Kawano N.:(1985) Phitochemistry ,24 , 115.
  48. Shin-Kim J.-S. :(1990) Dissertation , Universitat Bonn.
  49. Shin-Kim et Al. :(1993) A survey foraldose reductase inhibition of herbal medicines, Fitoterapia , L XIV, 2,130.
  50. Steinmetz E.F. :(1964) Poterii Spinosi Cortex Radicis , Quarterly Joumal of crude drug research ; Vol. IV ,NO.3: pp.582-588.ublisher :Dr. E.F.Steinmetz, 347 Keizersgracht, Amsterdam (Netherlands)
  51. Vaga E.G.:(1976) Curate il Diabete con le erbe Medicinali, Ed. De Vecchi, Milano.
  52. Vigneau C. :(1985) Plantes medicinales- Therapeutique- Toxicité, Collection de Médicine Légale et de Toxicologie Médicale N°129 . Ed. Masson-Paris.
  53. Vilain P. et al. :(1972) per l’azione vasodilatatrice sulle coronarie, Chem. Abstr. 76-117505d !972.
  54. Villar A., Paya M., Hortiguela M.D., Anselmi E.: (1984) Farm.Tiydschr. Belg. ,3,296.
  55. Villar A., Paya M., Hotriguela M.D., Cortes D: :(1986) Tormentic Acid , a new Hypoglycemic Agent from Poteriumancistroides . Planta Medica 52-43.
  56. Weiss R.F. :(1991) Lehrbuk der Phytotherapie , Ippokrates- Verlag, Stuttgard.
  57. Weiss R:F. :(1996) Trattato di Fitoterapia , Ed. Aporie, Roma.
Lagerstroemia speciosa
  1. Kakuda T., Sanake I., Takihara T., Ozaki Y., Tacheuki H., Kuroyanagi M.,“Hypoglicemic effect of extract from Lagerstroemia speciosa L. leaves in genetically diabetic KK-Ay mice”. Biosc. Biotechnol. Biochem. 1996 Feb; 60 (2): 204-208.
  2. Murakami, Myoga, Kasai, Ohtani,Kurokawa, Ishibashi,Dayrit,Padolina,Yamasaki,“Screening of plant constituents for effect on glucose transport activity in Erlich ascite tumour cells.”Chem. Pharm. Bull. (Tokio)Dic. 1993; 41 (12) : 2129-2131.
  3. Suzuki, Unno, Ushitani, Kakuda,“ Antiobesity activity of extracts of Lagerstroemia speciosa L. leaves on femaleKK-Ay mice” J. Nutr. Sci. Vitaminol (Tokio) Dic. 1999; 45 (6) : 791-795.
  4. Liu F.,Kim, Li y., Liu X. q., Li J., Chen X.,“ an extract of Lagerstroemia speciosahas insulin-like glucose uptake stimularory and adipocyte differentiation-inibitory activities in 3T3-L1 cells.” J. Nutr. 2001 Sep;131 (9): 2242-2247.
  5. Use Techno Corporation Inc.“ A single dose toxicity (limited dosage) study of CorosoLia B on rat” Study n. RA99014A
  6. Use Techno Corporation Inc.“Investigation of effects of CorosoLia B on blood sugar increase, in Streptozocin-induced diabetic rats.” Study n. RA99015Y
  7. Miyaji, Kazama, Ina, Yamada, Yamakawa,“ Influence of banaba-kuwa extracted powder on plasma glucose level in rat “ J. Of traditional medicines, 1999 (16) : 108-211.
Guggul
  1. Satyavati GV. Standardized extract a promising hypolipidaemic agent from gum guggul (Commiphora wightii) in Economic and Medicinal Plant Research, Volume 5H. Wagner and NR Farnsworth, eds. Academic Press: New York. 1991, p. 47-79.
  2. Kakrani HK, Guggul: A review. Indian Drugs 18: 417-421.
  3. Mitra AP, ed. The Wealth of India: A Dictionary of Indian Raw materials & Industrial Products: Raw Materials, Vol. 2:B. Publications & Information Directorate (CSIR): New Delhi, 1988.
  4. Swaminathan S, Bakshi RK, Dev S Higher isoprenoids XIX. Guggulsterones to dexamethasone. Tetrahedron 43(16):3827-3838, 1987.
  5. Patil VD, Nayak UR, Dev S. Chemistry of Ayurvedic crude drugs-part II: Guggul resin from Commiphora mukul-part II: Diterpenoid constituents. Tetrahedron 29(2):341-348, 1974.
  6. Patil VD, Nayak UR, Dev S. Chemistry of Ayurvedic crude drugs-part I: Steroidal constituents. Tetrahedron 28(8):2341-2352, 1972.
  7. Kakarani HK. Flavonoids from the flowers of Commiphora mukul. Fitoterapie, 1981. LII(5):221-222.
  8. Satyavati GV. Effact of an indigenous drug on disorders of lipid metabolism with special reference to atherosclerosis and obesity. 1966, Banaras Hindu University.
  9. Tripathi SN, Upadhyay BN. A clinical trial of Commiphora mukul in the petients of ischaemic heart disease. Journal of Molecular and Cellular Cardiology, 1978. 10(Suppl 1):124.
  10. Gopal K, et al. Clnical trial of ethyl acetate extract of gum guggulu (Standardized extract) in primary hyperlipidemia. Journal of the Associated Physicians of India, 1986. 34(4):249-251.
  11. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid: A new hypolipademic agent. Journal of the Associated Physicians of India, 1989. 37(5):323-328.
  12. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effect of Commiphora mukul as an adjunct to dietary therapy in patients with hypercolesterolemia. Cardiovascular Drug Therapy, 1994. 8(4):659-664.
  13. Gupta A, Kapoor NK, Nityanand S. Mechanism of hypolipidemic action of standardized extract.
  14. Singh V, et al. Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacological research, 1990. 22(1):37-43.
  15. Tripathi YB, et al. Thyroid stimulatory action of Z-guggulsterone obtained from Commiphora mukul. Planta Medica, 1984. Feb(1):78-80.
  16. Tripathi YB, et al. Thyroid stimulatory action of Z-guggulsterone: mechanism of action. Planta medica, 1988. 54(4):271-277.
  17. Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic, prevents oxidation of low density lipoprotein. Phytoteraphy Research, 1997. 1:291-294.
  18. Kaul S, Kapoor NK. Reversal of changes of lipid peroxide, xanthine oxidase and superoxide dismutase by cardio-protective drugs in isoprenol induced myocardial necrosis in rats. Indian Journal of Experimental Biology, 1989. 27:625-627.
  19. Mester L, Mester M, Nityanand S. Inhibition of platelet aggregation by “Guggulu” steroids. Planta Medica, 1979. 37:367-369.
  20. Hawkins EB. Guggul (Commiphora mukul): The cholesterol lowering botanical. Natural Pharmacy, 1998. 2(6). 32 Sharma SB, Dwivedi S. Review article-medicinal plants with hypolipidemic activities. Indian Drugs, 1997; 34(5):242-251.
  21. Bruneton J. Pharmacognosy, Phytochemistry Medicinal Plants. 1995, Paris, France: Lavoisier Publishing.
  22. Agarwal RC, et al. Clinical trial of standardized extract - a new hypolipidemic agent of plant origin in primary hyperlipidemia. Indian Journal of Medical Research, 1986. 84: 626-634.
  23. McGuffin M, et al., eds. American Herbal Product’s Association’s Botanical Safety Handbook. 1997, CRC Press, Inc.: Boca Raton, FL.
  24. Dalvi SS, et al. Effect of standardized extract on bioavailability of diltiazem and propranolol. Journal of the Associated Physicians of India.
  25. Thappa DM, Dogra J. Nodulocistic acne: oral gugulipid versus tetracycline. J Dermatol 1994 Oct; 21(10):729-31.